Bio-Techne (TECH) Payables (2010 - 2026)

Bio-Techne's Payables history runs 17 years deep, the most recent figure standing at $23.5 million for Q1 2026.

• In Q1 2026, Payables fell 25.77% year-over-year to $23.5 million; the TTM figure through Mar 2026 stood at $23.5 million (down 25.77% YoY), while the FY2025 annual figure was $25.3 million, down 33.34% from the prior year.
• Payables was $23.5 million for Q1 2026 at Bio-Techne, down from $26.3 million in the prior quarter.
• In the past five years, Payables ranged from a high of $38.0 million in Q2 2024 to a low of $23.5 million in Q1 2026.
• Historically, Payables has averaged $29.4 million across 5 years, with a median of $30.2 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Payables surged 47.86% in 2024, then slumped 33.34% in 2025.
• A 5-year view of Payables shows it stood at $24.1 million in 2022, then surged by 30.76% to $31.5 million in 2023, then advanced by 5.1% to $33.1 million in 2024, then declined by 20.69% to $26.3 million in 2025, then slipped by 10.58% to $23.5 million in 2026.
• The last three Payables figures came in at $23.5 million (Q1 2026), $26.3 million (Q4 2025), and $30.2 million (Q3 2025), per Business Quant data.